These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24366286)

  • 1. [Computed tomographic morphological evaluation of neoadjuvant chemotherapy. Effectiveness of the therapy for colorectal liver metastases].
    Folprecht G; Weitz J; Hoffmann RT
    Chirurg; 2014 Jan; 85(1):31-6. PubMed ID: 24366286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy].
    Lordick F; Knödler M; Hacker U; Bartels M
    Chirurg; 2014 Jan; 85(1):11-6. PubMed ID: 24292192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
    Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
    Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
    Takatsuki M; Tokunaga S; Uchida S; Sakoda M; Shirabe K; Beppu T; Emi Y; Oki E; Ueno S; Eguchi S; Akagi Y; Ogata Y; Baba H; Natsugoe S; Maehara Y;
    Eur J Surg Oncol; 2016 Feb; 42(2):184-9. PubMed ID: 26683263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.
    Egger ME; Cannon RM; Metzger TL; Nowacki M; Kelly L; Tatum C; Scoggins CR; Callender GG; McMasters KM; Martin RC
    J Am Coll Surg; 2013 Apr; 216(4):845-56; discussion 856-7. PubMed ID: 23415549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.
    Karagkounis G; Cai G; Johnson PT; Pawlik TM; Fishman EK; Choti MA
    Ann Surg Oncol; 2015 Jul; 22(7):2201-8. PubMed ID: 25582736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro primary surgery].
    Heinrich S; Lang H
    Chirurg; 2014 Jan; 85(1):17-23. PubMed ID: 24337153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].
    Reinacher-Schick AC; Bechstein WO
    Internist (Berl); 2007 Jan; 48(1):51-8. PubMed ID: 17160665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases.
    Brunsell TH; Cengija V; Sveen A; Bjørnbeth BA; Røsok BI; Brudvik KW; Guren MG; Lothe RA; Abildgaard A; Nesbakken A
    Eur J Surg Oncol; 2019 Dec; 45(12):2340-2346. PubMed ID: 31350075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer].
    Heinemann V; Löhe F
    MMW Fortschr Med; 2009 Jan; 151(5):35-7. PubMed ID: 19391410
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
    World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.
    Adam R; De Gramont A; Figueras J; Guthrie A; Kokudo N; Kunstlinger F; Loyer E; Poston G; Rougier P; Rubbia-Brandt L; Sobrero A; Tabernero J; Teh C; Van Cutsem E;
    Oncologist; 2012; 17(10):1225-39. PubMed ID: 22962059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectable colorectal liver metastases: optimal sequencing of chemotherapy.
    Chua TC; Morris DL
    J Gastrointest Cancer; 2012 Sep; 43(3):496-8. PubMed ID: 21365476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy affects staging of colorectal liver metastasis--a comparison of PET, CT and intraoperative ultrasound.
    Spatz J; Holl G; Sciuk J; Anthuber M; Arnholdt HM; Märkl B
    Int J Colorectal Dis; 2011 Feb; 26(2):165-71. PubMed ID: 20960208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
    Ke S; Zhan S; Zhu H; Yan D
    J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
    Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C
    Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.